Edgewise Therapeutics, Inc. (EWTX)

29.87 -0.25 (-0.83%) USD  |  NASDAQ  |  Feb 26, 10:04
More

Edgewise Therapeutics Net Non-Operating Interest Income Expense (Quarterly)

Net Non-Operating Interest Income Expense (Quarterly) Chart

View Net Non-Operating Interest Income Expense (Quarterly) for EWTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Non-Operating Interest Income Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks
Start Trial
Glaukos Corp. Upgrade
Nuvalent, Inc. Upgrade
Neurocrine Biosciences, Inc. --
Dynavax Technologies Corp. (DELISTED) Upgrade
Omeros Corp. Upgrade